| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 149.034 | 166.794 | 165.681 | 63.203 |
| Total Income - EUR | - | - | - | - | - | - | 149.034 | 168.194 | 166.917 | 92.920 |
| Total Expenses - EUR | - | - | - | - | - | - | 5.300 | 33.430 | 38.154 | 154.303 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 143.734 | 134.764 | 128.763 | -61.383 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 142.511 | 133.083 | 127.094 | -61.383 |
| Employees | - | - | - | - | - | - | 2 | 1 | 2 | 2 |
Check the financial reports for the company - Uroscan S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 25.271 | 112.001 | 185.684 | 86.497 |
| Current Assets | - | - | - | - | - | - | 119.004 | 307.062 | 217.906 | 264.278 |
| Inventories | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | - | 600 | 1.315 | 6.644 | 6.607 |
| Cash | - | - | - | - | - | - | 118.404 | 164.005 | 3.944 | 2.358 |
| Shareholders Funds | - | - | - | - | - | - | 142.551 | 274.662 | 400.923 | 337.300 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 1.724 | 144.617 | 2.699 | 13.676 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Uroscan S.r.l.